Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Rhinase


Not recommended
Risk of intrauterine growth retardation and neonatal adrenal insufficiency

Use under medical control
Rhinase :
Type Medicine Pending
Originator Flixonase Aqueous
Agent C. Catafago & Co
Distributor C. Catafago & Co
Laboratory Avalon
Manufacturer Middle East Pharmaceutical Industries Co Ltd - Avalon Pharma
Origin KSA
ATC R01AD08

Your comment will appear shortly after approval

Rhinase :

Revision Date : 23/04/2014


Effect Frequency
Anaphylactic reactions Very rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Very rare
Bronchospasm Very rare
Cataract Very rare
Dry throat Common
Epistaxis (Nasal bleeding) Very Common
Glaucoma Very rare
Headache Common
Hypersensitivity reactions Very rare
Intraocular pressure increased Very rare
Nasal dryness Common
Nasal irritation Common
Nasal septum perforation Very rare
Parosmia Common
Taste altered Common
Throat irritation Common

Different Units By MoH Code

Rhinase  MoH 2065439 :
Form Nasal spray, suspension
Packaging Bottle
Package Size 120 doses
Strength 50µg
Stratum N/A
NSSF ✔
Quarantine ✘
Reg. Number N/A
Submission date 19/08/2020
Pending Year 22/02/2023
Pending Reason Incomplete file


Price Comparison

● Country: KSA
● Package Size: 120
● Public Price: 22.1 SAR ( 522,444.00 LBP )
● Pack size unit used: 120
● Cost/Unit: 0,1842 SAR ( 0.00 LBP )
● Reference: sfda
● Pricing Date: 23/02/2023
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info